A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study-Reference-Cited by-同舟云学术

A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study

Published:1997-12 Issue:12 Volume:8 Page:1213-1220
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Fountzilas G.,Athanassiades A.,Giannakakis T.,Briasoulis E.,Bafaloukos D.,Kalogera-Fountzila A.,Onienaoum A.,Kalofonos H.,Pectasides D.,Andreopoulou E.,Bamia C.,Kosmidis P.,Pavlidis N.,Skarlos D.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/8/12/1213/19480463/8-12-1213.pdf

Reference43 articles.

1. Epirubicin: A review of the pharmacology, clinical activity and adverse effects of an adriamycin analogue;Gersosimo;J Clin Oncol,1986

2. Drugs ten years later: Epirubicin;Bonadonna;Ann Oncol,1993

3. Comparative studies of the uptake of daunorubicin in sensitive and resistant P388 cell lines by flow cytometry and biochemical extraction procedures;McGown;Cancer Chemother Pharmacol,1983

4. Escalating drug delivery in cancer chemotherapy: A review of concepts and practice – part 1;Gurney;Ann Oncol,1993

5. Effect of 4-doxorubicin analogs on heterotransplantation of human tumors in congeni-tally athymic mice;Giulani;Cancer Treat Rep,1981

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review;British Journal of Cancer;2017-10-24

2. A phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 (TOP1) gene: a study protocol;BMC Cancer;2015-02-21

3. Systematic review of efficacy of dose-dense versus non-dose-dense chemotherapy in breast cancer, non-Hodgkin lymphoma, and non-small cell lung cancer;Critical Reviews in Oncology/Hematology;2012-03

4. Fifteen-year trends in metastatic breast cancer survival in Greece;Breast Cancer Research and Treatment;2009-11-14

5. Objective Response to Chemotherapy As a Potential Surrogate End Point of Survival in Metastatic Breast Cancer Patients;Journal of Clinical Oncology;2005-08-01